Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is it Effective to Treat Patients With Blastocystis Hominis Infection? A Double-blind Placebo Controlled Randomized Trial

NCT01521403 is registered in ClinicalTrials.gov with University of Lausanne Hospitals as lead sponsor.

NCT NCT01521403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01521403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is it Effective to Treat Patients With Blastocystis Hominis Infection? A Double-blind Placebo Controlled Randomized Trial
Lead sponsor
University of Lausanne Hospitals
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2012
Completion date
December 30, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blastocystis hominis infections